Links

©Viva Biotech (Shanghai) Ltd. 沪ICP备12042930号   Powerd by 300.cn 

Viva Biotech and AlphaMa Reached Cooperation Agreement on IntelligentDEL (iDEL) Screening Platform

Classification:
News
Author:
Viva
Source:
Viva
2020/12/22 12:36
[Abstract]:
Viva Biotech will cooperate with AlphaMa to provide clients AI-based DNA coding compound library screening technology.

SHANGHAI, CHINA----Recently, Viva Biotech signed a new drug discovery technology cooperation agreement with AlphaMa Biotech Co., Ltd. (hereinafter referred to as "AlphaMa"). According to the agreement. Viva Biotech will cooperate with AlphaMa on innovative drug discovery technology to provide clients with the new generation of AI-based DNA coding compound library (Intelligent DEL, iDEL) screening technology platform for screening tumors and lead compounds for a series of specific targets in the field of neurological, autoimmune and other diseases......